31 results on '"Ritchie KJ"'
Search Results
2. Comparative Cytotoxicity of Glycyrrhiza glabra Roots from Different Geographical Origins Against Immortal Human Keratinocyte (HaCaT), Lung Adenocarcinoma (A549) and Liver Carcinoma (HepG2) Cells
- Author
-
Basar, N, Oridupa, OA, Ritchie, KJ, Nahar, L, Osman, NMM, Stafford, A, Kushiev, H, Kan, A, and Sarker, SD
- Subjects
QD ,R1 - Abstract
Glycyrrhiza glabra L. (Fabaceae), commonly known as 'liquorice', is a well-known medicinal plant. Roots of this plant have long been used as a sweetening and flavouring agent in food and pharmaceutical products, and also as a traditional remedy for cough, upper and lower respiratory ailments, kidney stones, hepatitis C, skin disorder, cardiovascular diseases, diabetes, gastrointestinal ulcers and stomach ache. Previous pharmacological and clinical studies have revealed its antitussive, antiinflammatory, antiviral, antimicrobial, antioxidant, immunomodulatory, hepatoprotective and cardioprotective properties. While glycyrrhizin, a sweet-tasting triterpene saponin, is the principal bioactive compound, several bioactive flavonoids and isoflavonoids are also present in the roots of this plant. In the present study, the cytotoxicity of the methanol extracts of nine samples of the roots of G.-glabra, collected from various geographical origins, was assessed against immortal human keratinocyte (HaCaT), lung adenocarcinoma (A549) and liver carcinoma (HepG2) cell lines using the in vitro 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazoliumbromide cell toxicity/viability assay. Considerable variations in levels of cytotoxicity were observed among various samples of G.-glabra.
3. Utilization of the ability to induce activation of the nuclear factor (erythroid-derived 2)-like factor 2 (Nrf2) to assess potential cancer chemopreventive activity of liquorice samples
- Author
-
Basar, N, Nahar, L, Oridupa, OA, Ritchie, KJ, Talukdar, AD, Stafford, A, Kushiev, H, Kan, A, and Sarker, SD
- Subjects
QD ,RS - Abstract
Introduction – Nuclear factor (erythroid-derived 2)-like factor 2 (Nrf2) is a transcription factor that regulates expression of many detoxification enzymes. Nrf2-antioxidant responsive element (Nrf2-ARE) signalling pathway can be a target for cancer chemoprevention. Glycyrrhiza glabra, common name, ‘liquorice’, is used as a sweetening and flavouring agent, and traditionally, to treat various ailments, and implicated to chemoprevention. However, its chemopreventive property has not yet been scientifically substantiated. \ud Objective – To assess the ability of liquorice root samples to induce Nrf2 activation correlating to their potential chemopreventive property. \ud Methods – The ability of nine methanolic extracts of liquorice root samples, collected from various geographical origins, to induce Nrf2 activation was determined by the luciferase reporter assay using the ARE-reporter cell line, AREc32. The antioxidant properties were determined by the 2,2-diphenyl-1-picryhydrazyl (DPPH) and the ferric-reducing antioxidant power (FRAP) assays. \ud Results – All extracts exhibited free-radical-scavenging property (RC50 = 136.39-635.66 g/mL). The reducing capacity of ferrous ion was 214.46-465.59 M Fe(II)/g. Nrf2 activation indicated that all extracts induced expression of ARE-driven luciferase activity with a maximum induction of 2.3 fold relative to control. These activities varied for samples from one geographical location to another. \ud Conclusions – The present findings add to the existing knowledge of cancer chemoprevention by plant-derived extracts or purified phytochemicals, particularly the potential use of liquorice for this purpose.
4. Flavonoids from two Turkish Centaurea species and their chemotaxonomic implications
- Author
-
Uddin, S, Alnsour, L, Segun, P, Servi, H, Celik, S, Gokturk, S, Al-Groshi, A, Al-Majmaie, S, Guetchueng, ST, Nahar, L, Dempster, NM, Ismail, FMD, Ritchie, KJ, and Sarker, SD
- Subjects
QH301 ,RV - Abstract
Centaurea asutro-anatolica Hub.-Mor. and C. kizildaghensis Uzunh., E. Doğan & H. Duman, two indigenous perennial herbs from the Turkish flora, belong to the medicinally important genus Centaurea L. (fam: Asteraceae), which comprises ca. 600 species worldwide. While various Centaurea species are well-known for producing alkaloids, flavonoids, lignans and terpenoids, there is no report on any thorough phytochemical work on any of these two species available to date. In continuation of our phytochemical and bioactivity studies on the Turkish Centaurea species, four flavonoids apigenin (1), apigenin 7,4’-dimethyl ether (2), genkwanin (3) and quercetin (4) were isolated from the methanol extracts of the aerial\ud parts of C. austro-anatolica and C. kizildaghensis, for the very first time. The structures of the flavonoids were elucidated conclusively by spectroscopic means, i.e., UV, MS and 1D and 2D NMR data analyses. The distribution of these flavonoids (1-4) within the genus Centaurea and their possible chemotaxonomic implications within the genus Centaurea or the family Asteraceae have been discussed.
5. Evaluation of the chemopreventive effect of selected medicinal plants extracts via induction of the Nrf2 in a modified model of breast cancer cells: identification of bioactive lead compounds.
- Author
-
Guetchueng ST, Nahar L, Ritchie KJ, and Sarker SD
- Subjects
- Female, Humans, Lead, Luciferases, NF-E2-Related Factor 2 genetics, NF-E2-Related Factor 2 metabolism, Plant Extracts pharmacology, Plant Extracts therapeutic use, Anticarcinogenic Agents pharmacology, Breast Neoplasms drug therapy, Breast Neoplasms prevention & control, Plants, Medicinal metabolism
- Abstract
The cancer chemopreventive potential of various solvent extracts from six medicinal plants was evaluated by their ability to activate the transcription factor Nrf2 using AREc32 cells, which contain a luciferase gene under the control of antioxidant responsive element promoters. Nrf2 regulates the expression of many detoxification enzymes, making it an ideal target for cancer prevention. The present research revealed Zanthoxylum zanthoxyloides extracts as promising sources of cancer chemopreventive compounds. Bioassay-guided isolation of the Z. Zanthoxyloides methanol extract resulted in the isolation of N-methylatanine, N-methylplatydesminecation, sesamin and skimmianine. Among these compounds, skimmianine was identified as the most active compound, causing a 2.8-fold increase in luciferase activity. Skimmianine and other related quinolone alkaloids could represent an appropriate starting scaffold for the development of new chemopreventive cancer drugs., (Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
6. Potent Nrf2-inducing, antioxidant, and anti-inflammatory effects and identification of constituents validate the anti-cancer use of Uvaria chamae and Olax subscorpioidea.
- Author
-
Popoola TD, Guetchueng ST, Ritchie KJ, Awodele O, Dempster NM, Akinloye O, Sarker SD, and Fatokun AA
- Subjects
- Anti-Inflammatory Agents pharmacology, Anti-Inflammatory Agents therapeutic use, Antineoplastic Agents therapeutic use, Antioxidants pharmacology, Antioxidants therapeutic use, Basic-Leucine Zipper Transcription Factors drug effects, Cell Survival drug effects, Cells, Cultured drug effects, Doxorubicin therapeutic use, Humans, Plant Extracts chemistry, Plant Roots chemistry, Plants, Medicinal chemistry, Streptomyces chemistry, Antineoplastic Agents pharmacology, Doxorubicin pharmacology, Neoplasms drug therapy, Olacaceae chemistry, Plant Extracts pharmacology, Plant Extracts therapeutic use, Uvaria chemistry
- Abstract
Background: Uvaria chamae (UC) and Olax subscorpioidea (OS) roots are included in traditional anti-cancer remedies and some studies have identified their chemopreventive/chemotherapeutic potential. This study aimed to identify some cellular/molecular mechanisms underlying such potential and the associated chemical constituents., Methods: Effect on the viability of cancer cells was assessed using the Alamar Blue assay; ability to modulate oxidative stress was assessed using the 2',7'-dichlorofluorescein diacetate (DCFDA) assay; potential to modulate Nuclear factor erythroid 2-related factor like-2 (Nrf2) activity was assessed in the AREc32 luciferase reporter cell line; and anti-inflammatory effect was assessed using lipopolysaccharide-induced nitric oxide release model in the RAW264.7 cells (Griess Assay). Chemical constituents were identified through liquid chromatography-mass spectrometry (LC-MS)., Results: Extracts up to 100 μg/ml were non-toxic or mildly toxic to HeLa, AREc32, PC3 and A549 cells (IC
50 > 200 μg/ml). Each extract reduced basal and peroxide-induced levels of reactive oxygen species (ROS) in HeLa cells. OS and UC activated Nrf2, with UC producing nearly four-fold induction. Both extracts demonstrated anti-inflammatory effects. Chamanetin, isochamanetin, isouvaretin, uvaricin I and other compounds were found in U. chamae root extract., Conclusion: As Nrf-2 induction, antioxidant and anti-inflammatory activities are closely linked with chemoprevention and chemotherapy of cancers, the roles of these plants in traditional anti-cancer remedies are further highlighted, as is their potential as sources of drug leads., (© 2021. The Author(s).)- Published
- 2021
- Full Text
- View/download PDF
7. Chalcones: Synthetic Chemistry Follows Where Nature Leads.
- Author
-
Jasim HA, Nahar L, Jasim MA, Moore SA, Ritchie KJ, and Sarker SD
- Subjects
- Cell Line, Drug Discovery, Humans, Structure-Activity Relationship, Anti-Bacterial Agents chemistry, Anti-Bacterial Agents pharmacology, Anti-Inflammatory Agents chemistry, Anti-Inflammatory Agents pharmacology, Antineoplastic Agents chemistry, Antineoplastic Agents pharmacology, Antioxidants chemistry, Antioxidants pharmacology, Biological Products chemistry, Biological Products pharmacology, Chalcones chemistry, Chalcones pharmacology
- Abstract
Chalcones belong to the flavonoid class of phenolic compounds. They form one of the largest groups of bioactive natural products. The potential anticancer, anti-inflammatory, antimicrobial, antioxidant, and antiparasitic properties of naturally occurring chalcones, and their unique chemical structural features inspired the synthesis of numerous chalcone derivatives. In fact, structural features of chalcones are easy to construct from simple aromatic compounds, and it is convenient to perform structural modifications to generate functionalized chalcone derivatives. Many of these synthetic analogs were shown to possess similar bioactivities as their natural counterparts, but often with an enhanced potency and reduced toxicity. This review article aims to demonstrate how bioinspired synthesis of chalcone derivatives can potentially introduce a new chemical space for exploitation for new drug discovery, justifying the title of this article. However, the focus remains on critical appraisal of synthesized chalcones and their derivatives for their bioactivities, linking to their interactions at the biomolecular level where appropriate, and revealing their possible mechanisms of action.
- Published
- 2021
- Full Text
- View/download PDF
8. Oxyresveratrol Modulates Genes Associated with Apoptosis, Cell Cycle Control and DNA Repair in MCF-7 Cells.
- Author
-
Radapong S, Chan K, Sarker SD, and Ritchie KJ
- Abstract
Oxyresveratrol (OXY) is a small molecule phytochemical which has been reported to have important biological function. The aim of this study was to elucidate the gene expression and biological pathways altered in MCF-7, breast cancer cells following exposure to OXY. The cytotoxicity to different cancer cell lines was screened using MTT assay and then whole gene expression was elucidated using microarray. The pathways selected were also validated by quantitative PCR analysis, fluorometric and western blot assay. A total of 686 genes were found to have altered mRNA expression levels of two-fold or more in the 50 μM OXY-treated group, while 2,338 genes were differentially expressed in the 100 µM-treated group. The relevant visualized global expression patterns of genes and pathways were generated. Apoptosis was activated through mitochondria-lost membrane potential, caspase-3 expression and chromatin condensation without DNA damage. G0/G1 and S phases of the cell cycle control were inhibited dose-dependently by the compound. Rad51 gene (DNA repair pathway) was significantly down-regulated ( p < 0.0001). These results indicate that OXY moderates key genes and pathways in MCF-7 cells and that it could be developed as a chemotherapy or chemo-sensitizing agent., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2021 Radapong, Chan, Sarker and Ritchie.)
- Published
- 2021
- Full Text
- View/download PDF
9. Oxyresveratrol Possesses DNA Damaging Activity.
- Author
-
Radapong S, Sarker SD, and Ritchie KJ
- Subjects
- Anthelmintics pharmacology, Antineoplastic Agents pharmacology, Antiparasitic Agents pharmacology, Antiviral Agents pharmacology, Chromatography, Chromatography, High Pressure Liquid, Copper chemistry, DNA chemistry, Ions, Magnetic Resonance Spectroscopy, Phytochemicals pharmacology, Powders, Reactive Oxygen Species chemistry, Stilbenes chemistry, Artocarpus chemistry, DNA drug effects, DNA Damage, Oxidants chemistry, Plant Extracts pharmacology, Stilbenes pharmacology
- Abstract
Artocarpus lakoocha Wall. ex Roxb. (family: Moraceae ) has been used as a traditional Thai medicine for the treatment of various parasitic diseases. This species has been reported to be the source of phytochemicals, which show potent biological activities. The objective of this study was to investigate the phytochemical profile of the extracts of the heartwood of A. lakoocha and their pro-oxidant activity in vitro. The heartwood was ground, extracted, and then chromatographic and spectroscopic analyses were carried out; oxyresveratrol was identified as the major component in the extracts. The pro-oxidant activity was investigated using DNA-nick, reactive oxygen species and reducing assays. The results showed that oxyresveratrol induced DNA damage dose-dependently in the presence of copper (II) ions. It was also found to generate reactive oxygen species (ROS) in a dose-dependent manner and reduce copper (II) to copper (I). It is concluded that oxyresveratrol is the most abundant stilbenoid in A. lakoocha heartwood. The compound exhibited pro-oxidant activity in the presence of copper (II) ions, which may be associated with its ability to act as an anticancer compound.
- Published
- 2020
- Full Text
- View/download PDF
10. Ent-Clerodane Diterpenes from the Bark of Croton oligandrus Pierre ex Hutch. and Assessment of Their Cytotoxicity against Human Cancer Cell Lines.
- Author
-
Guetchueng ST, Nahar L, Ritchie KJ, Ismail FMD, Evans AR, and Sarker SD
- Subjects
- A549 Cells, Antineoplastic Agents, Phytogenic isolation & purification, Antineoplastic Agents, Phytogenic pharmacology, Cell Line, Tumor, Cytotoxins isolation & purification, Cytotoxins pharmacology, Diterpenes, Clerodane isolation & purification, Diterpenes, Clerodane pharmacology, Furans isolation & purification, Furans pharmacology, Humans, Inhibitory Concentration 50, MCF-7 Cells, Molecular Structure, Pentacyclic Triterpenes isolation & purification, Pentacyclic Triterpenes pharmacology, Plant Extracts chemistry, Antineoplastic Agents, Phytogenic chemistry, Croton chemistry, Cytotoxins chemistry, Diterpenes, Clerodane chemistry, Furans chemistry, Pentacyclic Triterpenes chemistry, Plant Bark chemistry
- Abstract
New clerodane diterpenes, 12- epi -megalocarpodolide D ( 2 ) and an epimeric mixture of crotonolins A ( 3 ) and B ( 4 ), were isolated from the bark of Croton oligandrus following a bioassay-guided isolation protocol. Known compounds, megalocarpodolide D ( 1 ), 12- epi -crotocorylifuran ( 5 ), cluytyl-ferulate ( 6 ), hexacosanoyl- ferulate ( 7 ), vanillin ( 8 ), acetyl-aleuritolic acid ( 9 ) and lupeol ( 10 ), were also isolated. The structures of the isolated compounds ( 1 - 10 ) were elucidated by spectroscopic means. The cytotoxicity of compounds 1 - 10 was assessed against A549, MCF7, PC3 and PNT2 cell lines using the MTT assay. Compounds 1 and 2 showed moderate levels of activity against both A549 and MCF7 cells with 1 being the most active with IC
50 values of 63.8 ± 13.8 and 136.2 ± 22.7 µM against A549 and MCF7 cells, respectively. The epimeric mixture of 3 and 4 was moderately active against A549 and PC3 cells (IC50 = 128.6 ± 31.0 and 111.2 ± 2.9 µM, respectively)., Competing Interests: The authors declare no conflict of interest.- Published
- 2018
- Full Text
- View/download PDF
11. Microbial Factors Associated with Postoperative Crohn's Disease Recurrence.
- Author
-
Wright EK, Kamm MA, Wagner J, Teo SM, Cruz P, Hamilton AL, Ritchie KJ, Inouye M, and Kirkwood CD
- Subjects
- Adult, Colonoscopy methods, Female, Humans, Intestinal Mucosa microbiology, Intestinal Mucosa pathology, Male, Middle Aged, Proteus isolation & purification, Recurrence, Risk Factors, Statistics as Topic, Colectomy adverse effects, Colectomy methods, Crohn Disease microbiology, Crohn Disease pathology, Crohn Disease psychology, Crohn Disease surgery, Gastrointestinal Microbiome physiology, Ileum microbiology, Ileum pathology, Postoperative Complications diagnosis, Postoperative Complications microbiology, Postoperative Complications psychology, Smoking epidemiology, Smoking physiopathology
- Abstract
Background and Aims: The intestinal microbiota is a key antigenic driver in Crohn's disease [CD]. We aimed to identify changes in the gut microbiome associated with, and predictive of, disease recurrence and remission., Methods: A total of 141 mucosal biopsy samples from 34 CD patients were obtained at surgical resection and at colonoscopy 6 and/or 18 months postoperatively; 28 control samples were obtained: 12 from healthy patients [healthy controls] and 16 from hemicolectomy patients [surgical controls]. Bacterial 16S ribosomal profiling was performed using the Illumina MiSeq platform., Results: CD was associated with reduced alpha diversity when compared with healthy controls but not surgical controls [p < 0.001 and p = 0.666, respectively]. Beta diversity [composition] differed significantly between CD and both healthy [p < 0.001] and surgical [p = 0.022] controls, but did not differ significantly between those with and without endoscopic recurrence. There were significant taxonomic differences between recurrence and remission. Patients experiencing recurrence demonstrated elevated Proteus genera [p = 0.008] and reduced Faecalibacterium [p< 0.001]. Active smoking was associated with elevated levels of Proteus [p = 0.013] postoperatively. Low abundance of Faecalibacterium [< 0.1%] and detectable Proteus in the postoperative ileal mucosa was associated with a higher risk of recurrence (odds ratio [OR] 14 [1.7-110], p = 0.013 and 13 [1.1-150], p = 0.039, respectively) when corrected for smoking. A model of recurrence comprising the presence of Proteus, abundance of Faecalibacterium, and smoking status showed moderate accuracy (area under the curve [AUC] 0.740, 95% confidence interval [CI] [0.69-0.79])., Conclusions: CD is associated with a microbial signature distinct from health. Microbial factors and smoking independently influence postoperative CD recurrence. The genus Proteus may play a role in the development of CD., (Copyright © 2016 European Crohn’s and Colitis Organisation (ECCO). Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com.)
- Published
- 2017
- Full Text
- View/download PDF
12. Utilization of the Ability to Induce Activation of the Nuclear Factor (Erythroid-derived 2)-like Factor 2 (Nrf2) to Assess Potential Cancer Chemopreventive Activity of Liquorice Samples.
- Author
-
Basar N, Nahar L, Oridupa OA, Ritchie KJ, Talukdar AD, Stafford A, Kushiev H, Kan A, and Sarker SD
- Subjects
- Cell Line, Humans, Chemoprevention, Glycyrrhiza, NF-E2-Related Factor 2 metabolism
- Abstract
Introduction: Nuclear factor (erythroid-derived 2)-like factor 2 (Nrf2) is a transcription factor that regulates expression of many detoxification enzymes. Nrf2-antioxidant responsive element (Nrf2-ARE) signalling pathway can be a target for cancer chemoprevention. Glycyrrhiza glabra, common name, 'liquorice', is used as a sweetening and flavouring agent, and traditionally, to treat various ailments, and implicated to chemoprevention. However, its chemopreventive property has not yet been scientifically substantiated., Objective: To assess the ability of liquorice root samples to induce Nrf2 activation correlating to their potential chemopreventive property., Methods: The ability of nine methanolic extracts of liquorice root samples, collected from various geographical origins, to induce Nrf2 activation was determined by the luciferase reporter assay using the ARE-reporter cell line, AREc32. The antioxidant properties were determined by the 2,2-diphenyl-1-picryhydrazyl (DPPH) and the ferric-reducing antioxidant power (FRAP) assays., Results: All extracts exhibited free-radical-scavenging property (RC50 = 136.39-635.66 µg/mL). The reducing capacity of ferrous ion was 214.46-465.59 μM Fe(II)/g. Nrf2 activation indicated that all extracts induced expression of ARE-driven luciferase activity with a maximum induction of 2.3 fold relative to control. These activities varied for samples from one geographical location to another., Conclusions: The present findings add to the existing knowledge of cancer chemoprevention by plant-derived extracts or purified phytochemicals, particularly the potential use of liquorice for this purpose. Copyright © 2016 John Wiley & Sons, Ltd., (Copyright © 2016 John Wiley & Sons, Ltd.)
- Published
- 2016
- Full Text
- View/download PDF
13. Comparison of Fecal Inflammatory Markers in Crohn's Disease.
- Author
-
Wright EK, Kamm MA, De Cruz P, Hamilton AL, Ritchie KJ, Keenan JI, Leach S, Burgess L, Aitchison A, Gorelik A, Liew D, Day AS, and Gearry RB
- Subjects
- Adult, C-Reactive Protein metabolism, Colonoscopy, Crohn Disease surgery, Disease Progression, Endoscopy, Female, Follow-Up Studies, Humans, Inflammation etiology, Inflammation metabolism, Lactoferrin metabolism, Leukocyte L1 Antigen Complex metabolism, Male, Middle Aged, Postoperative Period, Prognosis, Prospective Studies, Recurrence, Remission Induction, Severity of Illness Index, Biomarkers metabolism, Crohn Disease complications, Feces chemistry, Inflammation diagnosis, Inflammation Mediators metabolism
- Abstract
Background: Fecal biomarkers are used increasingly to monitor Crohn's disease (CD). However, the relative accuracy of different markers in identifying inflammation has been poorly evaluated. We evaluated fecal calprotectin (FC), lactoferrin (FL), and S100A12 (FS) using endoscopic validation in a prospective study of the progression of CD after intestinal resection., Methods: Data were collected from 135 participants in a prospective, randomized, controlled trial aimed at preventing postoperative CD recurrence. Three hundred nineteen stool samples were tested for FC, FL, and FS preoperatively and 6, 12, and 18 months after resection. Colonoscopy was performed at 6 and/or 18 months. Endoscopic recurrence was assessed blindly using the Rutgeerts score. C-reactive protein (CRP) and Crohn's Disease Activity Index (CDAI) were assessed., Results: FC, FL, and FS concentrations were elevated preoperatively (median: 1347, 40.9, and 8.4 μg/g, respectively). At 6 months postoperatively, marker concentrations decreased (166, 3.0, 0.9 μg/g) and were higher in recurrent disease than remission (275 versus 72 μg/g, P < 0.001; 5.7 versus 1.6 μg/g, P = 0.007; 2.0 versus 0.8 μg/g, P = 0.188). FC > 135 μg/g, FL > 3.4 μg/g, and FS > 10.5 μg/g indicated endoscopic recurrence (score ≥ i2) with a sensitivity, specificity, and negative predictive value (NPV) of 0.87, 0.66, and 91%; 0.70, 0.68, and 81%; 0.91, 0.12, and 71%, respectively. FC and FL correlated significantly with the presence and severity of endoscopic recurrence, whereas FS, CRP and CDAI did not., Conclusions: FC was the optimal fecal marker for monitoring disease activity in postoperative CD and was superior to CRP and CDAI. FL offered modest sensitivity for detecting recurrent disease, whereas S100A12 was sensitive but had low specificity and NPV.
- Published
- 2016
- Full Text
- View/download PDF
14. Cost-effectiveness of Crohn's disease post-operative care.
- Author
-
Wright EK, Kamm MA, Dr Cruz P, Hamilton AL, Ritchie KJ, Bell SJ, Brown SJ, Connell WR, Desmond PV, and Liew D
- Subjects
- Adolescent, Adult, Australia, Biomarkers metabolism, Cost-Benefit Analysis, Crohn Disease diagnosis, Drug Costs, Feces chemistry, Female, Hospital Costs, Humans, Leukocyte L1 Antigen Complex metabolism, Male, New Zealand, Predictive Value of Tests, Prospective Studies, Recurrence, Time Factors, Treatment Outcome, Young Adult, Colonoscopy economics, Crohn Disease economics, Crohn Disease surgery, Health Care Costs, Immunosuppressive Agents economics, Immunosuppressive Agents therapeutic use, Postoperative Care economics
- Abstract
Aim: To define the cost-effectiveness of strategies, including endoscopy and immunosuppression, to prevent endoscopic recurrence of Crohn's disease following intestinal resection., Methods: In the "POCER" study patients undergoing intestinal resection were treated with post-operative drug therapy. Two thirds were randomized to active care (6 mo colonoscopy and drug intensification for endoscopic recurrence) and one third to drug therapy without early endoscopy. Colonoscopy at 18 mo and faecal calprotectin (FC) measurement were used to assess disease recurrence. Administrative data, chart review and patient questionnaires were collected prospectively over 18 mo., Results: Sixty patients (active care n = 43, standard care n = 17) were included from one health service. Median total health care cost was $6440 per patient. Active care cost $4824 more than standard care over 18 mo. Medication accounted for 78% of total cost, of which 90% was for adalimumab. Median health care cost was higher for those with endoscopic recurrence compared to those in remission [$26347 (IQR 25045-27485) vs $2729 (IQR 1182-5215), P < 0.001]. FC to select patients for colonoscopy could reduce cost by $1010 per patient over 18 mo. Active care was associated with 18% decreased endoscopic recurrence, costing $861 for each recurrence prevented., Conclusion: Post-operative management strategies are associated with high cost, primarily medication related. Calprotectin use reduces costs. The long term cost-benefit of these strategies remains to be evaluated.
- Published
- 2016
- Full Text
- View/download PDF
15. Efficacy of thiopurines and adalimumab in preventing Crohn's disease recurrence in high-risk patients - a POCER study analysis.
- Author
-
De Cruz P, Kamm MA, Hamilton AL, Ritchie KJ, Krejany EO, Gorelik A, Liew D, Prideaux L, Lawrance IC, Andrews JM, Bampton PA, Jakobovits S, Florin TH, Gibson PR, Debinski H, Gearry RB, Macrae FA, Leong RW, Kronborg I, Radford-Smith G, Selby W, Johnston MJ, Woods R, Elliott PR, Bell SJ, Brown SJ, Connell WR, and Desmond PV
- Subjects
- Adult, Aged, Azathioprine adverse effects, Colonoscopy methods, Crohn Disease diagnosis, Drug Therapy, Combination, Female, Follow-Up Studies, Humans, Male, Mercaptopurine adverse effects, Metronidazole adverse effects, Middle Aged, Postoperative Period, Recurrence, Risk Factors, Treatment Outcome, Tumor Necrosis Factor-alpha antagonists & inhibitors, Tumor Necrosis Factor-alpha immunology, Adalimumab therapeutic use, Azathioprine administration & dosage, Crohn Disease prevention & control, Crohn Disease surgery, Mercaptopurine administration & dosage, Metronidazole administration & dosage
- Abstract
Background: Crohn's disease recurs in the majority of patients after intestinal resection., Aim: To compare the relative efficacy of thiopurines and anti-TNF therapy in patients at high risk of disease recurrence., Methods: As part of a larger study comparing post-operative management strategies, patients at high risk of recurrence (smoker, perforating disease, ≥2nd operation) were treated after resection of all macroscopic disease with 3 months metronidazole together with either azathioprine 2 mg/kg/day or mercaptopurine 1.5 mg/kg/day. Thiopurine-intolerant patients received adalimumab induction then 40 mg fortnightly. Patients underwent colonoscopy at 6 months with endoscopic recurrence assessed blind to treatment., Results: A total of 101 patients [50% male; median (IQR) age 36 (25-46) years] were included. There were no differences in disease history between thiopurine- and adalimumab-treated patients. Fifteen patients withdrew prior to 6 months, five due to symptom recurrence (of whom four were colonoscoped). Endoscopic recurrence (Rutgeerts score i2-i4) occurred in 33 of 73 (45%) thiopurine vs. 6 of 28 (21%) adalimumab-treated patients [intention-to-treat (ITT); P = 0.028] or 24 of 62 (39%) vs. 3 of 24 (13%) respectively [per-protocol analysis (PPA); P = 0.020]. Complete mucosal endoscopic normality (Rutgeerts i0) occurred in 17/73 (23%) vs. 15/28 (54%) (ITT; P = 0.003) and in 27% vs. 63% (PPA; P = 0.002). The most advanced disease (Rutgeerts i3 and i4) occurred in 8% vs. 4% (thiopurine vs. adalimumab)., Conclusions: In Crohn's disease patients at high risk of post-operative recurrence adalimumab is superior to thiopurines in preventing early disease recurrence., (© 2015 John Wiley & Sons Ltd.)
- Published
- 2015
- Full Text
- View/download PDF
16. Comparative Cytotoxicity of Glycyrrhiza glabra Roots from Different Geographical Origins Against Immortal Human Keratinocyte (HaCaT), Lung Adenocarcinoma (A549) and Liver Carcinoma (HepG2) Cells.
- Author
-
Basar N, Oridupa OA, Ritchie KJ, Nahar L, Osman NM, Stafford A, Kushiev H, Kan A, and Sarker SD
- Subjects
- Adenocarcinoma pathology, Adenocarcinoma of Lung, Carcinoma, Hepatocellular pathology, Cell Line, Tumor drug effects, Flavonoids chemistry, Geography, Humans, Inhibitory Concentration 50, Liver Neoplasms pathology, Lung Neoplasms pathology, Molecular Structure, Plant Extracts chemistry, Plant Roots chemistry, Saponins chemistry, Triterpenes chemistry, Flavonoids pharmacology, Glycyrrhiza chemistry, Keratinocytes drug effects, Plant Extracts pharmacology, Saponins pharmacology, Triterpenes pharmacology
- Abstract
Glycyrrhiza glabra L. (Fabaceae), commonly known as 'liquorice', is a well-known medicinal plant. Roots of this plant have long been used as a sweetening and flavouring agent in food and pharmaceutical products, and also as a traditional remedy for cough, upper and lower respiratory ailments, kidney stones, hepatitis C, skin disorder, cardiovascular diseases, diabetes, gastrointestinal ulcers and stomach ache. Previous pharmacological and clinical studies have revealed its antitussive, antiinflammatory, antiviral, antimicrobial, antioxidant, immunomodulatory, hepatoprotective and cardioprotective properties. While glycyrrhizin, a sweet-tasting triterpene saponin, is the principal bioactive compound, several bioactive flavonoids and isoflavonoids are also present in the roots of this plant. In the present study, the cytotoxicity of the methanol extracts of nine samples of the roots of G. glabra, collected from various geographical origins, was assessed against immortal human keratinocyte (HaCaT), lung adenocarcinoma (A549) and liver carcinoma (HepG2) cell lines using the in vitro 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazoliumbromide cell toxicity/viability assay. Considerable variations in levels of cytotoxicity were observed among various samples of G. glabra., (Copyright © 2015 John Wiley & Sons, Ltd.)
- Published
- 2015
- Full Text
- View/download PDF
17. Effect of intestinal resection on quality of life in Crohn's disease.
- Author
-
Wright EK, Kamm MA, De Cruz P, Hamilton AL, Ritchie KJ, Krejany EO, Gorelik A, Liew D, Prideaux L, Lawrance IC, Andrews JM, Bampton PA, Sparrow MP, Florin TH, Gibson PR, Debinski H, Gearry RB, Macrae FA, Leong RW, Kronborg I, Radford-Smith G, Selby W, Johnston MJ, Woods R, Elliott PR, Bell SJ, Brown SJ, Connell WR, and Desmond PV
- Subjects
- Adalimumab therapeutic use, Adult, Anti-Inflammatory Agents, C-Reactive Protein metabolism, Cecum surgery, Colectomy, Colonoscopy, Feces chemistry, Female, Follow-Up Studies, Humans, Ileum surgery, Immunosuppressive Agents therapeutic use, Leukocyte L1 Antigen Complex analysis, Male, Middle Aged, Prospective Studies, Recurrence, Remission Induction, Severity of Illness Index, Sex Factors, Smoking adverse effects, Surveys and Questionnaires, Time Factors, Watchful Waiting, Young Adult, Crohn Disease surgery, Quality of Life
- Abstract
Introduction: Patients with Crohn's disease have poorer health-related quality of life [HRQoL] than healthy individuals, even when in remission. Although HRQoL improves in patients who achieve drug-induced or surgically induced remission, the effects of surgery overall have not been well characterised., Methods: In a randomised trial, patients undergoing intestinal resection of all macroscopically diseased bowel were treated with postoperative drug therapy to prevent disease recurrence. All patients were followed prospectively for 18 months. C-reactive protein [CRP], Crohn's Disease Activity Index [CDAI], and faecal calprotectin [FC] were measured preoperatively and at 6, 12, and 18 months. HRQoL was assessed with a general [SF36] and disease-specific [IBDQ] questionnaires at the same time points., Results: A total of 174 patients were included. HRQoL was poor preoperatively but improved significantly [p < 0.001] at 6 months postoperatively. This improvement was sustained at 18 months. Females and smokers had a poorer HRQoL when compared with males and non-smokers, respectively. Persistent endoscopic remission, intensification of drug treatment at 6 months, and anti-tumour necrosis factor therapy were not associated with HRQoL outcomes different from those when these factors were not present. There was a significant inverse correlation between CDAI, [but not endoscopic recurrence, CRP, or FC] on HRQoL., Conclusion: Intestinal resection of all macroscopic Crohn's disease in patients treated with postoperative prophylactic drug therapy is associated with significant and sustained improvement in HRQoL irrespective of type of drug treatment or endoscopic recurrence. HRQoL is lower in female patients and smokers. A higher CDAI, but not direct measures of active disease or type of drug therapy, is associated with a lower HRQoL., (Copyright © 2015 European Crohn’s and Colitis Organisation (ECCO). Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com.)
- Published
- 2015
- Full Text
- View/download PDF
18. Measurement of fecal calprotectin improves monitoring and detection of recurrence of Crohn's disease after surgery.
- Author
-
Wright EK, Kamm MA, De Cruz P, Hamilton AL, Ritchie KJ, Krejany EO, Leach S, Gorelik A, Liew D, Prideaux L, Lawrance IC, Andrews JM, Bampton PA, Jakobovits SL, Florin TH, Gibson PR, Debinski H, Macrae FA, Samuel D, Kronborg I, Radford-Smith G, Selby W, Johnston MJ, Woods R, Elliott PR, Bell SJ, Brown SJ, Connell WR, Day AS, Desmond PV, and Gearry RB
- Subjects
- Adult, Australia, Biomarkers metabolism, C-Reactive Protein metabolism, Colonoscopy, Crohn Disease diagnosis, Crohn Disease metabolism, Female, Humans, Male, Middle Aged, New Zealand, Predictive Value of Tests, Prospective Studies, Recurrence, Remission Induction, Time Factors, Treatment Outcome, Crohn Disease surgery, Feces chemistry, Leukocyte L1 Antigen Complex metabolism
- Abstract
Background & Aims: Crohn's disease (CD) usually recurs after intestinal resection; postoperative endoscopic monitoring and tailored treatment can reduce the chance of recurrence. We investigated whether monitoring levels of fecal calprotectin (FC) can substitute for endoscopic analysis of the mucosa., Methods: We analyzed data collected from 135 participants in a prospective, randomized, controlled trial, performed at 17 hospitals in Australia and 1 hospital in New Zealand, that assessed the ability of endoscopic evaluations and step-up treatment to prevent CD recurrence after surgery. Levels of FC, serum levels of C-reactive protein (CRP), and Crohn's disease activity index (CDAI) scores were measured before surgery and then at 6, 12, and 18 months after resection of all macroscopic Crohn's disease. Ileocolonoscopies were performed at 6 months after surgery in 90 patients and at 18 months after surgery in all patients., Results: Levels of FC were measured in 319 samples from 135 patients. The median FC level decreased from 1347 μg/g before surgery to 166 μg/g at 6 months after surgery, but was higher in patients with disease recurrence (based on endoscopic analysis; Rutgeerts score, ≥i2) than in patients in remission (275 vs 72 μg/g, respectively; P < .001). Combined 6- and 18-month levels of FC correlated with the presence (r = 0.42; P < .001) and severity (r = 0.44; P < .001) of CD recurrence, but the CRP level and CDAI score did not. Levels of FC greater than 100 μg/g indicated endoscopic recurrence with 89% sensitivity and 58% specificity, and a negative predictive value (NPV) of 91%; this means that colonoscopy could have been avoided in 47% of patients. Six months after surgery, FC levels less than 51 μg/g in patients in endoscopic remission predicted maintenance of remission (NPV, 79%). In patients with endoscopic recurrence at 6 months who stepped-up treatment, FC levels decreased from 324 μg/g at 6 months to 180 μg/g at 12 months and 109 μg/g at 18 months., Conclusions: In this analysis of data from a prospective clinical trial, FC measurement has sufficient sensitivity and NPV values to monitor for CD recurrence after intestinal resection. Its predictive value might be used to identify patients most likely to relapse. After treatment for recurrence, the FC level can be used to monitor response to treatment. It predicts which patients will have disease recurrence with greater accuracy than CRP level or CDAI score., (Copyright © 2015 AGA Institute. Published by Elsevier Inc. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
19. Crohn's disease management after intestinal resection: a randomised trial.
- Author
-
De Cruz P, Kamm MA, Hamilton AL, Ritchie KJ, Krejany EO, Gorelik A, Liew D, Prideaux L, Lawrance IC, Andrews JM, Bampton PA, Gibson PR, Sparrow M, Leong RW, Florin TH, Gearry RB, Radford-Smith G, Macrae FA, Debinski H, Selby W, Kronborg I, Johnston MJ, Woods R, Elliott PR, Bell SJ, Brown SJ, Connell WR, and Desmond PV
- Subjects
- Adalimumab, Adult, Antibodies, Monoclonal, Humanized administration & dosage, Azathioprine therapeutic use, Colonoscopy, Crohn Disease pathology, Crohn Disease surgery, Female, Humans, Male, Mercaptopurine therapeutic use, Metronidazole therapeutic use, Middle Aged, Recurrence, Treatment Outcome, Crohn Disease therapy
- Abstract
Background: Most patients with Crohn's disease need an intestinal resection, but a majority will subsequently experience disease recurrence and require further surgery. This study aimed to identify the optimal strategy to prevent postoperative disease recurrence., Methods: In this randomised trial, consecutive patients from 17 centres in Australia and New Zealand undergoing intestinal resection of all macroscopic Crohn's disease, with an endoscopically accessible anastomosis, received 3 months of metronidazole therapy. Patients at high risk of recurrence also received a thiopurine, or adalimumab if they were intolerant to thiopurines. Patients were randomly assigned to parallel groups: colonoscopy at 6 months (active care) or no colonoscopy (standard care). We used computer-generated block randomisation to allocate patients in each centre to active or standard care in a 2:1 ratio. For endoscopic recurrence (Rutgeerts score ≥i2) at 6 months, patients stepped-up to thiopurine, fortnightly adalimumab with thiopurine, or weekly adalimumab. The primary endpoint was endoscopic recurrence at 18 months. Patients and treating physicians were aware of the patient's study group and treatment, but central reading of the endoscopic findings was undertaken blind to the study group and treatment. Analysis included all patients who received at least one dose of study drug. This trial is registered with ClinicalTrials.gov, number NCT00989560., Findings: Between Oct 13, 2009, and Sept 28, 2011, 174 (83% high risk across both active and standard care groups) patients were enrolled and received at least one dose of study drug. Of 122 patients in the active care group, 47 (39%) stepped-up treatment. At 18 months, endoscopic recurrence occurred in 60 (49%) patients in the active care group and 35 (67%) patients in the standard care group (p=0.03). Complete mucosal normality was maintained in 27 (22%) of 122 patients in the active care group versus four (8%) in the standard care group (p=0.03). In the active care arm, of those with 6 months recurrence who stepped up treatment, 18 (38%) of 47 patients were in remission 12 months later; conversely, of those in remission at 6 months who did not change therapy recurrence occurred in 31 (41%) of 75 patients 12 months later. Smoking (odds ratio [OR] 2.4, 95% CI 1.2-4.8, p=0.02) and the presence of two or more clinical risk factors including smoking (OR 2.8, 95% CI 1.01-7.7, p=0.05) increased the risk of endoscopic recurrence. The incidence and type of adverse and severe adverse events did not differ significantly between patients in the active care and standard care groups (100 [82%] of 122 vs 45 [87%] of 52; p=0.51) and (33 [27%] of 122 vs 18 [35%] of 52; p=0.36), respectively., Interpretation: Treatment according to clinical risk of recurrence, with early colonoscopy and treatment step-up for recurrence, is better than conventional drug therapy alone for prevention of postoperative Crohn's disease recurrence. Selective immune suppression, adjusted for early recurrence, rather than routine use, leads to disease control in most patients. Clinical risk factors predict recurrence, but patients at low risk also need monitoring. Early remission does not preclude the need for ongoing monitoring., Funding: AbbVie, Gutsy Group, Gandel Philanthropy, Angior Foundation, Crohn's Colitis Australia, and the National Health and Medical Research Council., (Copyright © 2015 Elsevier Ltd. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
20. Increased skin papilloma formation in mice lacking glutathione transferase GSTP.
- Author
-
Henderson CJ, Ritchie KJ, McLaren A, Chakravarty P, and Wolf CR
- Subjects
- Animals, Apoptosis, Cell Proliferation, Glutathione S-Transferase pi genetics, Mice, Oxidative Stress, Papilloma enzymology, Papilloma pathology, Skin Neoplasms enzymology, Skin Neoplasms pathology, Tetradecanoylphorbol Acetate pharmacology, Glutathione S-Transferase pi physiology, Papilloma etiology, Skin Neoplasms etiology
- Abstract
The glutathione S-transferase GSTP is overexpressed in many human cancers and chemotherapy-resistant cancer cells, where there is evidence that GSTP may have additional functions beyond its known catalytic role. On the basis of evidence that Gstp-deficient mice have a comparatively higher susceptibility to skin carcinogenesis, we investigated whether this phenotype reflected an alteration in carcinogen detoxification or not. For this study, Gstp(-/-) mice were interbred with Tg.AC mice that harbor initiating H-ras mutations in the skin. Gstp(-/-)/Tg.AC mice exposed to the proinflammatory phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA) exhibited higher tumor incidence and multiplicity with a significant thickening of skin after treatment, illustrating hyperproliferative growth. Unexpectedly, we observed no difference in cellular proliferation or apoptosis or in markers of oxidative stress, although higher levels of the inflammatory marker nitrotyrosine were found in Gstp(-/-)/Tg.AC mice. Instead, gene set enrichment analysis of microarray expression data obtained from skin revealed a more proapoptotic and proinflammatory environment shortly after TPA treatment. Within 4 weeks of TPA treatment, Gstp(-/-)/Tg.AC mice displayed altered lipid/sterol metabolism and Wnt signaling along with aberrant processes of cytoskeletal control and epidermal morphogenesis at both early and late times. In extending the evidence that GSTP has a vital role in normal homeostatic control and cancer prevention, they also strongly encourage the emerging concept that GSTP is a major determinant of the proinflammatory character of the tumor microenvironment. This study shows that the GSTP plays a major role in carcinogenesis distinct from its role in detoxification and provides evidence that the enzyme is a key determinant of the proinflammatory tumor environment., (©2011 AACR)
- Published
- 2011
- Full Text
- View/download PDF
21. Markedly enhanced colon tumorigenesis in Apc(Min) mice lacking glutathione S-transferase Pi.
- Author
-
Ritchie KJ, Walsh S, Sansom OJ, Henderson CJ, and Wolf CR
- Subjects
- Adenoma enzymology, Adenoma pathology, Animals, Cell Movement, Colon enzymology, Colon pathology, Enterocytes pathology, Inflammation pathology, Mice, Oxidative Stress, Survival Analysis, Adenomatous Polyposis Coli Protein metabolism, Colonic Neoplasms enzymology, Colonic Neoplasms pathology, Glutathione S-Transferase pi deficiency, Precancerous Conditions enzymology, Precancerous Conditions pathology
- Abstract
Glutathione transferases are a multigene family of proteins that catalyze the conjugation of toxic electrophiles and carcinogens to glutathione. Glutathione transferase Pi (GSTP) is commonly overexpressed in human tumors and there is emerging evidence that the enzyme has additional cellular functions in addition to its role in drug and carcinogen detoxification. To investigate the unique functions of this enzyme, we have crossed Gstp null mice with an initiated model of colon cancer, the Apc(Min) mouse. In contrast to the Apc(Min/+) Gstp1/p2(+/+) (Gstp-wt Apc(Min)) mice, which rarely develop colonic tumours, Apc(Min/+)Gstp1/p2(-/-) (Gstp-null Apc(Min)) mice had a 6-fold increase in colon adenoma incidence, and a 50-fold increase in colorectal adenoma multiplicity, relative to Gstp-wt Apc(Min). This increase was associated with early tumor onset and decreased survival. Analysis of the biochemical changes in the colon tissue of Gstp-null Apc(Min) mice demonstrated a marked induction of many inflammatory genes, including IL-6, IL-4, IFN-gamma, and inducible nitric oxide synthase. In support of the induction of inducible nitric oxide synthase, a profound induction of nitrotyrosine adducts was observed. Gstp therefore appears to play a role in controlling inflammatory responses in the colon, which would explain the change in tumor incidence observed. These data also suggest that individual variation in GSTP levels may be a factor in colon cancer susceptibility.
- Published
- 2009
- Full Text
- View/download PDF
22. Glutathione transferase pi plays a critical role in the development of lung carcinogenesis following exposure to tobacco-related carcinogens and urethane.
- Author
-
Ritchie KJ, Henderson CJ, Wang XJ, Vassieva O, Carrie D, Farmer PB, Gaskell M, Park K, and Wolf CR
- Subjects
- 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide, Animals, Benzo(a)pyrene, DNA Adducts biosynthesis, Female, Gene Expression Profiling, Glutathione S-Transferase pi deficiency, Glutathione S-Transferase pi genetics, Lung metabolism, MAP Kinase Kinase 4 metabolism, Male, RNA, Messenger biosynthesis, RNA, Messenger genetics, Nicotiana, Urethane, Adenoma chemically induced, Adenoma enzymology, Carcinogens, Glutathione S-Transferase pi metabolism, Lung Neoplasms chemically induced, Lung Neoplasms enzymology
- Abstract
Human cancer is controlled by a complex interaction between genetic and environmental factors. Such environmental factors are well defined for smoking-induced lung cancer; however, the roles of specific genes have still to be elucidated. Glutathione transferase pi (GSTP) catalyzes the detoxification of electrophilic diol epoxides produced by the metabolism of polycyclic aromatic hydrocarbons such as benzo[a]pyrene (BaP), a common constituent of tobacco smoke. Activity-altering polymorphisms in Gstp have therefore been speculated to be potential risk modifiers in lung cancer development. To clearly establish a role for GSTP in lung tumorigenesis, we investigated whether deletion of the murine Gstp genes (Gstp1 and Gstp2) alters susceptibility to chemically induced lung tumors following exposure to BaP, 3-methylcholanthrene (3-MC), and urethane. Gstp-null mice were found to have substantially increased numbers of adenomas relative to wild-type mice following exposure to all three compounds (8.3-, 4.3-, and 8.7-fold increase for BaP, 3-MC, and urethane, respectively). In Gstp-null mice, the capacity of pulmonary cytosol to catalyze conjugation of the BaP diol epoxide was significantly reduced. Concomitant with this, a significant increase in the level of BaP DNA adducts was measured in the lungs of null animals; however, no increase in DNA adducts was measured in the case of 3-MC exposure, suggesting that an alternative protective pathway exists. Indeed, significant differences in pulmonary gene expression profiles were also noted between wild-type and null mice. This is the first report to establish a clear correlation between Gstp status and lung cancer in vivo.
- Published
- 2007
- Full Text
- View/download PDF
23. Development of a liquid chromatography-electrospray ionization tandem mass spectrometry method for detecting oxaliplatin-DNA intrastrand cross-links in biological samples.
- Author
-
Le Pla RC, Ritchie KJ, Henderson CJ, Wolf CR, Harrington CF, and Farmer PB
- Subjects
- Animals, Antineoplastic Agents therapeutic use, Cisplatin metabolism, Cisplatin pharmacology, Cisplatin toxicity, Cross-Linking Reagents chemistry, DNA metabolism, DNA Adducts analysis, DNA Adducts metabolism, Mice, Mice, Knockout, Organoplatinum Compounds metabolism, Organoplatinum Compounds pharmacology, Oxaliplatin, Tissue Distribution, Antineoplastic Agents pharmacology, Chromatography, Liquid methods, Cross-Linking Reagents metabolism, DNA analysis, Organoplatinum Compounds toxicity, Spectrometry, Mass, Electrospray Ionization methods, Tandem Mass Spectrometry methods
- Abstract
Cellular resistance, both intrinsic and acquired, poses a problem in the effectiveness of platinum-based chemotherapy. The cytotoxic activity of Pt-based chemotherapeutic agents is derived from their ability to react with cellular DNA. Oxaliplatin binds to the N7 position of the purine DNA bases, forming mainly intrastrand cross-links between either two adjacent guanines (GG), an adjacent adenine and guanine (AG), or two guanines separated by an unmodified nucleotide (GNG). We report the development of a liquid chromatography-electrospray ionization tandem mass spectrometry (LC-ESI-MS/MS) method for measuring GG and AG intrastrand cross-links formed by oxaliplatin. The limits of detection for GG-oxPt and AG-oxPt were 23 and 19 adducts per 10 (8) nucleotides, respectively. We compare the formation and persistence of intrastrand cross-links between wild-type and glutathione transferase P null mice (GSTP null) treated with oxaliplatin. No significant difference was observed in the level of intrastrand cross-links formed by oxaliplatin between the mouse strains in liver, kidney, and lung DNA. Adduct levels were greatest in liver and lowest in lung tissue.
- Published
- 2007
- Full Text
- View/download PDF
24. Ubp43 regulates BCR-ABL leukemogenesis via the type 1 interferon receptor signaling.
- Author
-
Yan M, Luo JK, Ritchie KJ, Sakai I, Takeuchi K, Ren R, and Zhang DE
- Subjects
- Animals, Endopeptidases deficiency, Endopeptidases immunology, Fusion Proteins, bcr-abl, Leukemia, Myelogenous, Chronic, BCR-ABL Positive etiology, Mice, Mice, Knockout, Ubiquitin Thiolesterase, Endopeptidases physiology, Immunity, Innate, Leukemia, Myelogenous, Chronic, BCR-ABL Positive immunology, Protein-Tyrosine Kinases, Receptor, Interferon alpha-beta metabolism, Signal Transduction immunology
- Abstract
Interferon (IFN) signaling induces the expression of interferon-responsive genes and leads to the activation of pathways that are involved in the innate immune response. Ubp43 is an ISG15-specific isopeptidase, the expression of which is activated by IFN. Ubp43 knock-out mice are hypersensitive to IFN-alpha/beta and have enhanced resistance to lethal viral and bacterial infections. Here we show that in addition to protection against foreign pathogens, Ubp43 deficiency increases the resistance to oncogenic transformation by BCR-ABL. BCR-ABL viral transduction/transplantation of wild-type bone marrow cells results in the rapid development of a chronic myeloid leukemia (CML)-like myeloproliferative disease; in contrast, a significantly increased latency of disease development is observed following BCR-ABL viral transduction/transplantation of Ubp43-deficient bone marrow cells. This resistance to leukemic development is dependent on type 1 IFN (IFN-alpha/beta) signaling in Ubp43-deficient cells. Increased levels of type 1 IFN are also detected in the serum of CML mice. These results suggest that inhibition of Ubp43-negative effect on IFN signaling can potentiate the response to increased endogenous IFN levels in innate immune responses against cancer development, indicating that pharmacological inhibition of Ubp43 may be of benefit in cancers and others diseases in which interferon is currently prescribed.
- Published
- 2007
- Full Text
- View/download PDF
25. Ubp43 gene expression is required for normal Isg15 expression and fetal development.
- Author
-
Rempel LA, Austin KJ, Ritchie KJ, Yan M, Shen M, Zhang DE, Henkes LE, and Hansen TR
- Subjects
- Animals, Cell Hypoxia genetics, Cytokines metabolism, Embryo Implantation genetics, Endopeptidases metabolism, Female, Gene Expression Regulation, Developmental, Male, Mice, Mice, Inbred C57BL, Mice, Knockout, Models, Biological, Neovascularization, Physiologic genetics, Placenta anatomy & histology, Placenta metabolism, Pregnancy, Ubiquitin Thiolesterase, Ubiquitins genetics, Ubiquitins metabolism, Cytokines genetics, Endopeptidases genetics, Fetal Development genetics, Pregnancy, Animal
- Abstract
Background: Isg15 covalently modifies murine endometrial proteins in response to early pregnancy. Isg15 can also be severed from targeted proteins by a specific protease called Ubp43 (Usp18). Mice lacking Ubp43 (null) form increased conjugated Isg15 in response to interferon. The Isg15 system has not been examined in chorioallantoic placenta (CP) or mesometrial (MM) components of implantation sites beyond 9.5 days post coitum (dpc). It was hypothesized that deletion of Ubp43 would cause disregulation of Isg15 in implantation sites, and that this would affect pregnancy rates., Methods: Heterozygous (het) Ubp43 mice were mated and MM and CP implantation sites were collected on 12.5 and 17.5 days post-coitum (dpc)., Results: Free and conjugated Isg15 were greater on 12.5 versus 17.5 dpc in MM. Free and conjugated Isg15 were also present in CP, but did not differ due to genotype on 12.5 dpc. However, null CP had greater free and conjugated Isg15 when compared to het/wt on 17.5 dpc. Null progeny died in utero with fetal genotype ratios (wt:het:null) of 2:5:1 on 12.5 and 2:2:1 on 17.5 dpc. Implantation sites were disrupted within the junctional zone and spongiotrophoblast, contained less vasculature based on lectin B4 staining and contained greater Isg15 mRNA and VEGF protein in Ubp43 null when compared to wt placenta., Conclusion: It is concluded that Isg15 and its conjugates are present in implantation sites during mid to late gestation and that deletion of Ubp43 causes an increase in free and conjugated Isg15 at the feto-maternal interface. Also, under mixed genetic background, deletion of Ubp43 results in fetal death.
- Published
- 2007
- Full Text
- View/download PDF
26. Role of ISG15 protease UBP43 (USP18) in innate immunity to viral infection.
- Author
-
Ritchie KJ, Hahn CS, Kim KI, Yan M, Rosario D, Li L, de la Torre JC, and Zhang DE
- Subjects
- Animals, Antigens, Viral metabolism, Blotting, Northern, Blotting, Western, Brain metabolism, Endopeptidases immunology, Endopeptidases metabolism, Fibroblasts drug effects, Fibroblasts virology, Humans, Immunohistochemistry, Macrophages drug effects, Macrophages virology, Mice, T-Lymphocytes immunology, Ubiquitin Thiolesterase, Cytokines metabolism, Endopeptidases pharmacology, Immunity, Innate immunology, Lymphocytic choriomeningitis virus immunology, RNA metabolism, Ubiquitins analogs & derivatives, Ubiquitins metabolism, Vesicular stomatitis Indiana virus immunology, Virus Replication drug effects
- Abstract
Innate immune responses provide the host with an early protection barrier against infectious agents, including viruses, and help shape the nature and quality of the subsequent adaptive immune responses of the host. Expression of ISG15 (UCRP), a ubiquitin-like protein, and protein ISGylation are highly increased upon viral infection. We have identified UBP43 (USP18) as an ISG15 deconjugating protease. Protein ISGylation is enhanced in cells deficient in UBP43 (ref. 6). Here we have examined the role of UBP43, encoded by the gene Usp18, in innate immunity to virus infection. Usp18(-/-) mice were resistant to the fatal lymphocytic choriomeningitis and myeloencephalitis that developed in wild-type mice after intracerebral inoculation with lymphocytic choriomeningitis virus (LCMV) or vesicular stomatitis virus (VSV), respectively. Survival of Usp18(-/-) mice after intracerebral LCMV infection correlated with a severe inhibition of LCMV RNA replication and antigen expression in the brain and increased levels of protein ISGylation. Consistent with these findings, mouse embryonic fibroblasts (MEF) and bone marrow-derived macrophages from Usp18(-/-) mice showed restricted LCMV replication. Moreover, MEF from Usp18(-/-) mice showed enhanced interferon-mediated resistance to the cytopathic effect caused by VSV and Sindbis virus (SNV). This report provides the first direct evidence that the ISG15 protease UBP43 and possibly protein ISGylation have a role in innate immunity against viral infection.
- Published
- 2004
- Full Text
- View/download PDF
27. ISG15: the immunological kin of ubiquitin.
- Author
-
Ritchie KJ and Zhang DE
- Subjects
- Amino Acid Sequence, Animals, Base Sequence, Humans, Molecular Sequence Data, Signal Transduction, Ubiquitins chemistry, Ubiquitins genetics, Immunity, Innate, Ubiquitins immunology, Ubiquitins metabolism
- Abstract
Since the discovery of ubiquitin in 1975, the poly-ubiquitylation pathway has earned a prominent place in biomedical research as the "garbage disposal" system of the cell. Modification with poly-ubiquitin chains plays an important role in normal protein turnover and also in removing damaged or misfolded proteins. More recently, the elucidation of mono-ubiquitylation of protein substrates has shown additional important roles for ubiquitylation in processes, such as transcriptional regulation, viral budding, and receptor internalization. Intriguingly, this voyage of discovery is now repeating itself with a new generation of ubiquitin-like (ubl) modifiers, such as SUMO and NEDD8. The functional consequences of SUMO and NEDD8 modification are thus beginning to be revealed. A less known member of this ubiquitin-like family is ISG 15, a modifier encoded by an interferon-stimulated gene. Recent publications have ascribed important functions for this molecule in various biological pathways from pregnancy to innate immune responses. Furthermore, ISG 15 has been found to modify several important molecules and affect type I interferon signal transduction. Here, we review ISG 15-related work and highlight important biological questions which need to be posed in order to further elucidate the biological consequences of ISG15 and ISG15 modification.
- Published
- 2004
- Full Text
- View/download PDF
28. Protein ISGylation modulates the JAK-STAT signaling pathway.
- Author
-
Malakhova OA, Yan M, Malakhov MP, Yuan Y, Ritchie KJ, Kim KI, Peterson LF, Shuai K, and Zhang DE
- Subjects
- Animals, Apoptosis drug effects, Bone Marrow Transplantation, Cytokines drug effects, Endopeptidases metabolism, Hematopoietic Stem Cells drug effects, Humans, Interferon Inducers pharmacology, Interferon-beta metabolism, Interferon-beta pharmacology, Janus Kinase 1, K562 Cells drug effects, Ligases genetics, Ligases metabolism, Mice, Mice, Inbred C57BL, Mice, Mutant Strains, Phosphorylation, Poly I-C pharmacology, Promoter Regions, Genetic, Protein-Tyrosine Kinases drug effects, STAT1 Transcription Factor, Signal Transduction, Tyrosine, Ubiquitin Thiolesterase, Ubiquitin-Protein Ligases, Cytokines metabolism, DNA-Binding Proteins metabolism, Endopeptidases genetics, Protein-Tyrosine Kinases metabolism, Trans-Activators metabolism, Ubiquitins analogs & derivatives
- Abstract
ISG15 is one of the most strongly induced genes upon viral infection, type I interferon (IFN) stimulation, and lipopolysaccharide (LPS) stimulation. Here we report that mice lacking UBP43, a protease that removes ISG15 from ISGylated proteins, are hypersensitive to type I IFN. Most importantly, in UBP43-deficient cells, IFN-beta induces a prolonged Stat1 tyrosine phosphorylation, DNA binding, and IFN-mediated gene activation. Furthermore, restoration of ISG15 conjugation in protein ISGylation-defective K562 cells increases IFN-stimulated promoter activity. These findings identify UBP43 as a novel negative regulator of IFN signaling and suggest the involvement of protein ISGylation in the regulation of the JAK-STAT pathway.
- Published
- 2003
- Full Text
- View/download PDF
29. Dysregulation of protein modification by ISG15 results in brain cell injury.
- Author
-
Ritchie KJ, Malakhov MP, Hetherington CJ, Zhou L, Little MT, Malakhova OA, Sipe JC, Orkin SH, and Zhang DE
- Subjects
- Animals, Blood-Brain Barrier physiology, Endopeptidases deficiency, Endopeptidases genetics, Ependyma metabolism, Ependyma pathology, Gene Expression, Hydrocephalus genetics, Hydrocephalus metabolism, Hydrocephalus pathology, Mice, Mice, Knockout, Necrosis, Phenotype, Protein Processing, Post-Translational, RNA, Messenger genetics, RNA, Messenger metabolism, Ubiquitin Thiolesterase, Ubiquitins, Brain metabolism, Brain pathology, Cytokines metabolism, Endopeptidases metabolism
- Abstract
UBP43 (USP18) is a protease that removes the ubiquitin-like modifier ISG15 from conjugated proteins. Here we present the first report of dysregulation of protein ISG15 modification by the generation of UBP43 knockout mice. In the absence of UBP43, brain tissue showed an elevated level of ISG15 conjugates, and cellular necrosis was evident in the ependyma. Such disruption of the blood-brain barrier resulted in severe neurologic disorders. These results demonstrate that UBP43 plays a critical role in maintaining the homeostatic balance of ISG15-conjugated protein, and that regulation of cellular levels of ISG15 protein modification is essential for brain cell function.
- Published
- 2002
- Full Text
- View/download PDF
30. UBP43 (USP18) specifically removes ISG15 from conjugated proteins.
- Author
-
Malakhov MP, Malakhova OA, Kim KI, Ritchie KJ, and Zhang DE
- Subjects
- Animals, Blotting, Western, Cell Line, DNA, Complementary metabolism, Humans, Hydrolysis, Lung metabolism, Mice, Plasmids metabolism, Protein Binding, Substrate Specificity, Ubiquitin Thiolesterase, Cytokines metabolism, Endopeptidases metabolism, Escherichia coli metabolism, Ubiquitins analogs & derivatives
- Abstract
UBP43 shows significant homology to well characterized ubiquitin-specific proteases and previously was shown to hydrolyze ubiquitin-beta-galactosidase fusions in Escherichia coli. In our assays, the activity of UBP43 toward Ub fusions was undetectable in vitro directing us to investigate the possibility of Ub-like proteins such as SUMO, Nedd8, and ISG15 as probable substrates. We consequently demonstrate that UBP43 can efficiently cleave only ISG15 fusions including native ISG15 conjugates linked via isopeptide bonds. In addition to commonly used methods we introduce a new experimental design featuring ISG15-UBP43 fusion self-processing. Deletion of the UBP43 gene in mouse leads to a massive increase of ISG15 conjugates in tissues indicating that UBP43 is a major ISG15-specific protease. UBP43 is the first bona fide ISG15-specific protease reported. Both ISG15 and UBP43 genes are known to be strongly induced by interferon, genotoxic stress, and viral infection. We postulate that UBP43 is necessary to maintain a critical cellular balance of ISG15-conjugated proteins in both healthy and stressed organisms.
- Published
- 2002
- Full Text
- View/download PDF
31. Are cancer patients subject to employment discrimination?
- Author
-
Rothstein MA, Kennedy K, Ritchie KJ, and Pyle K
- Subjects
- Adolescent, Adult, Age Factors, Aged, Career Mobility, Female, Humans, Male, Middle Aged, Occupations, Sex Factors, Unemployment, Work Schedule Tolerance, Employment, Neoplasms, Prejudice
- Abstract
We sought to determine whether patients undergoing treatment for cancer had experienced discrimination in employment and, if so, how that discrimination was manifested. We also sought to determine what variables affected the rate of discrimination, including age, gender, occupation, and employer size. We surveyed 422 patients diagnosed with cancer who were being treated at an acute-care, comprehensive cancer center in Houston, Texas, or were being followed after therapy. Whereas 76% of respondents indicated that they were working at the time of diagnosis and 82% said that they wanted to work full- or part-time, only 56% were working at the time of the study. Type of occupation was the main determinant of whether individuals were employed after diagnosis. The study documents self-reported discrimination in employment on the basis of cancer. Additional research is needed to determined the measures, including legal recourse, necessary to enable cancer patients to obtain and continue work.
- Published
- 1995
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.